Synopsis of recent research by authors named "Zegang Ma"
- Zegang Ma's research primarily focuses on the neuroprotective effects of cannabinoid receptor activation, particularly the cannabinoid type 2 (CB2) receptors, in various neurodegenerative diseases such as Parkinson's disease and ischemic stroke, with findings indicating potential therapeutic applications.
- Recent studies by Ma reveal that compounds like β-Caryophyllene and JWH133 can mitigate neuronal damage and improve functional outcomes in animal models of ischemic stroke and Parkinson's disease by inhibiting neuroinflammation and pyroptosis.
- In addition to neuropharmacology, Ma has also investigated public health aspects, such as preferences for COVID-19 vaccination, indicating a multidisciplinary approach to his research agenda encompassing both neurobiological and socio-economic perspectives.
